Parallel Advisors, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$150,017
-51.2%
3,975
-41.1%
0.01%
-50.0%
Q2 2023$307,555
+14.7%
6,750
+2.1%
0.01%
+11.1%
Q1 2023$268,221
+58.0%
6,612
+98.6%
0.01%
+28.6%
Q4 2022$169,715
-32.7%
3,329
-28.9%
0.01%
-41.7%
Q3 2022$252,000
-21.2%
4,680
-6.0%
0.01%
-20.0%
Q2 2022$320,000
-28.7%
4,981
-11.9%
0.02%
-16.7%
Q1 2022$449,000
-29.2%
5,657
-23.4%
0.02%
-25.0%
Q4 2021$634,000
+12.0%
7,384
+5.0%
0.02%
+4.3%
Q3 2021$566,000
+3.3%
7,033
+3.3%
0.02%0.0%
Q2 2021$548,000
+8.3%
6,810
+13.6%
0.02%
-4.2%
Q1 2021$506,000
+11.7%
5,997
+6.1%
0.02%
-4.0%
Q4 2020$453,000
-4.6%
5,652
-4.4%
0.02%
-13.8%
Q3 2020$475,000
-10.5%
5,912
-4.2%
0.03%
-17.1%
Q2 2020$531,000
+2.9%
6,174
-3.0%
0.04%
-16.7%
Q1 2020$516,000
+5.7%
6,363
+9.0%
0.04%
+13.5%
Q4 2019$488,000
-20.3%
5,836
-16.6%
0.04%
-28.8%
Q3 2019$612,000
+9.9%
6,994
+2.9%
0.05%
-3.7%
Q2 2019$557,0000.0%6,798
-0.8%
0.05%
-14.3%
Q1 2019$557,000
+18.3%
6,854
-4.3%
0.06%
-4.5%
Q4 2018$471,000
-12.9%
7,160
+1.9%
0.07%
-1.5%
Q3 2018$541,000
+4.4%
7,024
+0.0%
0.07%
-9.5%
Q2 2018$518,000
+8.6%
7,023
-4.3%
0.07%0.0%
Q1 2018$477,000
-5.0%
7,338
-5.5%
0.07%
-9.8%
Q4 2017$502,000
+0.4%
7,7610.0%0.08%
-4.7%
Q3 2017$500,000
+4.4%
7,761
-2.1%
0.09%
-4.4%
Q2 2017$479,000
-44.8%
7,928
-48.9%
0.09%
+4.7%
Q1 2017$868,000
+416.7%
15,516
+310.6%
0.09%
+120.5%
Q4 2016$168,0003,7790.04%
Other shareholders
BAXTER INTL INC shareholders Q4 2021
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders